EUVIMEDEUVIMED entdecken
Open Access

Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs

Gavin R McGivney iD, Qierra R Brockman iD, Nicholas Borcherding iD, Amanda Scherer iD, Adam J Rauckhorst iD, Wade R Gutierrez iD, Shane R Solst iD, Collin D Heer, Akshaya Warrier iD, Warren Floyd, David G Kirsch, Vickie L Knepper-Adrian iD und 5 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.adu2906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Gavin R McGivney und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52240, USA. Hauptthemen laut MEDLINE: Pentose Phosphate Pathway, CRISPR-Cas Systems, Carcinogenesis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive and chemo-resistant sarcomas with poor survival rates. Loss of CDKN2A or P53 following NF1 disruption is a key event in MPNST development. Here, we used CRISPR-Cas9 somatic tumorigenesis in mice to identify transcriptomic and metabolomic features distinguishing CDKN2A - versus P53 -deleted MPNSTs. Convergent, multiomic analyses revealed that CDKN2A -deleted MPNSTs are especially dependent on the pentose phosphate pathway (PPP) and NADPH metabolism for growth and viability. Disruption of glucose-6-phosphate dehydrogenase (G6PD), the PPP rate-limiting enzyme, slowed CDKN2A -deleted MPNST growth and sensitized MPNSTs to standard-of-care chemotherapy. Knockdown of the redox-regulated transcription factor NRF2 slowed MPNST growth and decreased G6PD transcription. Analysis of patient MPNSTs identified a NRF2 gene signature correlating with tumor transformation. Furthermore, G6PD and NRF2 expression in PanCancer TCGA samples correlates with patient survival. This work identifies NRF2-PPP dependency as a targetable vulnerability in these difficult-to-treat MPNSTs, particularly in the NF1/CDKN2A -deleted majority.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pentose Phosphate PathwayCRISPR-Cas SystemsCarcinogenesisAnimalsMiceNF-E2-Related Factor 2HumansGlucosephosphate DehydrogenaseCyclin-Dependent Kinase Inhibitor p16Tumor Suppressor Protein p53Gene Expression Regulation, NeoplasticNADPCell Line, Tumor

Substanzen

NF-E2-Related Factor 2Glucosephosphate DehydrogenaseCyclin-Dependent Kinase Inhibitor p16Tumor Suppressor Protein p53NADP

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52240, USA.
  • Holden Comprehensive Cancer Center, University of Iowa Carver College of Medicine, Iowa City, IA 52240, USA.
  • Department of Molecular Physiology and Biophysics, University of Iowa Carver College of Medicine, Iowa City, IA 52240, USA.
  • Department of Medicine, Anschutz Medical Campus, University of Colorado Cancer Center, Aurora, CO 80045, USA.
  • Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Fraternal Order of Eagles Diabetes Research Center (FOEDRC), University of Iowa Carver College of Medicine, Iowa City, IA 52240, USA.

ORCID-Profile: Gavin R McGivney, Qierra R Brockman, Nicholas Borcherding, Amanda Scherer, Adam J Rauckhorst, Wade R Gutierrez, Shane R Solst, Akshaya Warrier, Vickie L Knepper-Adrian, Emily A Laverty, Douglas R Spitz, Eric B Taylor, Rebecca D Dodd

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS

Zitieren

APA

McGivney, G. R., Brockman, Q. R., Borcherding, N., Scherer, A., Rauckhorst, A. J., Gutierrez, W. R., Solst, S. R., Heer, C. D., Warrier, A., Floyd, W., Kirsch, D. G., Knepper-Adrian, V. L., Laverty, E. A., Roughton, G. A., Spitz, D. R., Taylor, E. B., & Dodd, R. D. (2025). Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs. Science Advances. https://doi.org/10.1126/sciadv.adu2906

Vancouver

McGivney GR, Brockman QR, Borcherding N, Scherer A, Rauckhorst AJ, Gutierrez WR, et al. Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs. Science Advances. 2025. doi:10.1126/sciadv.adu2906

BibTeX
@article{McGivney2025,
  author = {McGivney, Gavin R and Brockman, Qierra R and Borcherding, Nicholas and Scherer, Amanda and Rauckhorst, Adam J and Gutierrez, Wade R and Solst, Shane R and Heer, Collin D and Warrier, Akshaya and Floyd, Warren and Kirsch, David G and Knepper-Adrian, Vickie L and Laverty, Emily A and Roughton, Grace A and Spitz, Douglas R and Taylor, Eric B and Dodd, Rebecca D},
  title = {Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adu2906}
}
Kostenlos starten →